We also observed regional heterogeneity in genes associated with poor clinical prognosis in IDH-mutant glioma, including CDKN2A/B, CDK4, MYC, MYCN, and PDGFRA23 (Fig. 2b, Supplementary Fig. 1; Supplementary Data 1). This evidence concerns the gene CDK4 and central nervous system cancer.